| HOME >> BIOLOGY >> TECHNOLOGY |
Mr. Bonifant has been a management consultant for nearly 15 years, helping leaders of global pharmaceuticals and biotechnology organizations and decision makers in large private equity funds. His perspectives on developments in the life sciences market are frequently published in industry and strategy journals, and he is a frequent guest lecturer at some of the nation's premier universities. Mr. Bonifant earned an MBA from the Stanford Graduate School of Business.
For more information on Windhover's Pharmaceutical Strategic Alliances conference, please visit http://www.windhover.com/psa.
About the Business Development Practice at Campbell Alliance
The Business Development Practice at Campbell Alliance helps licensing executives achieve an edge over the competition. Our consultants provide experienced counsel to clients who need assistance developing business development strategies, identifying partners, prioritizing targets, evaluating opportunities, and negotiating deals.
The firm's team includes seasoned consultants and industry professionals in pharmaceutical and biotech business development who have identified, assessed, and executed numerous in-licensing deals. They have also been valuable in aiding out-licensors, helping clients improve internal processes for pharmaceutical business development, and assisting top executives chart new strategies in corporate development.
About Campbell Alliance
Campbell Alliance is the leading management consulting firm
specializing in the pharmaceutical and biotechnology industries. The firm's
clients include most of the world's top 20 pharmaceutical companies, as
well as numerous emerging and midsize firms. Campbell Alliance
'/>"/>
| SOURCE Campbell Alliance Copyright©2007 PR Newswire. All rights reserved |